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Abstract
Through nutrient recovery by urine separation, the VUNA project aims to develop
an effective sanitation system that simultaneously helps address important issues
such as environmental pollution and water scarcity. Refinement of the nutrient
recovery process presents several challenges: at a technical level, as nitrifying
bacteria are sensitive to several parameters; and from a public health perspective,
as nutrient recovery from urine implies exposure to pathogens.
As part of this problematic, the present study focused on four main objectives:
operating nitrification reactors, characterising both virus and bacteria inactiva-
tion, and evaluating different inactivation mechanisms.
Indicator organisms (bacteriophages and bacteria) were used as surrogates for
human pathogens. In a first set of experiments, the bacteriophage MS2 was
spiked continuously over 60 days in a continuous flow nitrification reactor.
Nitrification did not affect the bacteriophage concentration within the reactor.
The second set of experiments consisted of the operation of small scale batch
and semi-batch reactors to test in total three different bacteriophages (ΦX147,
MS2, Qbeta) and two bacteria (Salmonella typhimerium, Enterococcus spp.)
under varying parameters.
Pathogens can be inactivated or affected by different mechanisms. Four possible
inactivation mechanisms were further evaluated: 1) effect of biological activity
in a nitrification treatment system, 2) effect of the air-water interface in a buffer
(PBS) and nitrified urine, 3) effect of the complexity of solution, 4) effect of
ambient temperature.
Results indicated that nitrification caused bacterial inactivation but did not
influence the bacteriophages concentration. Air-water interface did not affect
bacteria and showed mixed results for bacteriophages. Ambient temperature
was not an inactivating parameter for neither of the groups studied. Finally, the
bacteriophages presented signs of resistance, possibly due to a protective effect
of the complex solution in the nitrification reactor.
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1 Introduction
1.1 VUNA Project
The VUNA project, which stands for the Valorisation of Urine Nutrients in Africa,
aims to promote sanitation and nutrient recovery through urine separation. The
project was launched in 2010 by the Swiss Federal Institute of Aquatic Science
and Technology (Eawag) with the University of KwaZulu-Natal (UKZN) and
eThekwini Water and Sanitation (EWS) in South Africa, as well as the Swiss
Federal Institute of Technology (ETHZ). Through the recovery of nutrient from
urine in small decentralised reactors, the VUNA projects pursue several over-
arching objectives: improvement of sanitation, reduction of pollution of water
resources, and promotion of entrepreneurship [1].
Urine contains the major fraction of nutrients found in human excreta: 80-90%
of the nitrogen, 55-67% of the phosphorus and 50-80% of the potassium [4, 5, 6].
Because of its composition, the use of urine as fertilizer is an obvious application.
Harvesting urine is not only interesting for developing the use of an alternative
fertilizer. It would also reduce the effects of pollution from unsafe excreta dis-
posal, and lower the ecological burden of the fertilizer production and surplus use
of chemical fertilizers [4, 7]. Finally, it would promote wastewater management
systems that reduce both water use and initial infrastructure investments [8].
Urine needs processing for several purposes: hygienisation, volume reduction,
urine stabilisation, nutrient recovery (N, P), nutrient removal and handling of
micropollutants [9]. Urine treatment and nutrient recovery pose many challenges
in terms of technology but also in terms of health. Indeed, the handling and reuse
of human waste always involves hygiene risks [6]. In order to have a successful
alternative wastewater system and nutrient recovery process, the hygiene risk
assessment is of utmost importance.
Research at Eawag has focused, amongst other technologies, on biological nitrifi-
cation for urine stabilisation, followed by distillation for nutrient recovery. Nitrifi-
cation reactor parameters have been optimised for nitrification performance and
end product quality. The LCE at EPFL joined the VUNA project for research on
pathogen inactivation during urine treatment. Pathogen inactivation during urine
storage and struvite fertilizer production have already been studied [10, 11], and
the mechanisms of inactivation by ammonia are under investigation. The steps
where possible pathogen inactivation is to be assessed by VUNA researchers are:
storage, struvite fertilizer production, electrolysis and nitrification.
1
1.2 Microbial health risks of source-separated urine
Urine of healthy people is usually sterile, but some pathogens (e.g. Leptospira
interrogans, Salmonella typhi, Salmonella paratyphi and Schistosoma haemato-
bium) can be excreted during infection [10]. On the other hand, human faeces
contain high levels of disease-causing organisms, such as bacteria, viruses, par-
asitic protozoa and helminths, in concentrations depending on their prevalence
within a given population [12]. These pathogens, principally affecting the gas-
trointestinal system, are of significant world-health concern. 1.7 million deaths
per year world-wide, mainly caused by infectious diarrhoea, are due to poor water
quality, sanitation and hygiene [13]. Overall, 99.8% of the sanitation-, water-
and hygiene-related death occurs in developing countries and 90% are deaths of
children under 5 years [14, 15].
Excreta-related pathogens are diverse and cause various infections. For example
the gram-negative bacteria Escherichia coli, Vibrio cholerae, Salmonella spp.,
Shigella spp. induce severe vomiting, diarrhea, typhoid fever and other infections
[12]. Viruses, including hepatitis A and E, adenovirus, rotavirus, and norovirus are
also found in excreta [12]. For example, hepatitis A causes severe liver damages,
while rotavirus and adenovirus cause diarrheal diseases.
A main contamination pathway of enteric pathogens in urine is cross-
contamination of source-separated urine with pathogens from faeces. Schönning
et al. studied cross-contamination in Sweden and Australia and found up to
22-37% of contamination in their samples [6]. Recent sampling in urine storage
tanks in Durban revealed the presence of ten pathogens : seven types of bacteria
were detected in 11% to 94% of the samples (over 18 samples); adenovirus and
rotavirus were detected in 31-34% of the samples (over 29 samples) and norovirus
GI in 3% (over 29 samples) [16]. The need of protection against pathogens and
further investigation is thus confirmed.
In order to develop a sustainable nutrient recovery process, the end-product
should be safe to manipulate. A complete nutrient recovery system comprises
several steps: household storage, transport, storage tank, nitrification reactor,
distillation, fertilizer, and human exposure to pathogens is possible at each step.
Applying unsafe fertilizer also presents risks for the environment [17]. To ensure
complete safety, the risk of exposure to pathogens must be assessed at each step
and appropriate protective measures must be taken.
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Figure 1: Schematic drawing of urine collection and processing into fertilizer[1]
1.3 Aim of the study
The overall aim of this study is to assess the inactivation of pathogens during
biological nitrification, with the specific research objectives as follows:
1. Install, maintain and operate continuous flow nitrification reactors
2. Characterise virus inactivation
3. Characterise bacteria inactivation
4. Assess physical, biological and chemical inactivation mechanisms
To address these objectives, two continuous flow nitrification reactors and sev-
eral batch and semi-batch reactors were set-up and monitored. Little is known
regarding pathogen inactivation mechanisms during nitrification. Postulated in-
activation methods are outlined in chapter 2.2.3. Indicator organisms (bacte-
riophages and bacteria) were used as surrogates for human pathogens to study
the inactivation. Several types of bacteriophage and bacteria were tested, with
varying experimental parameters, in order to evaluate causal connection between
pathogen inactivation and reactor conditions.
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4
2 Theory and literature review
2.1 Nitrification process
In fresh source-separated urine 75-90% of N is excreted as urea (CO(NH2)2) [5].
Fresh urine also contains salts, soluble organic matter and ammonia bound to
urea [9]. Due to microbial activity, the urea in urine is hydrolysed during storage
and transport. The overall reaction of urea hydrolysis, or ureolysis, is expressed
as follows [18]:
NH2(CO)NH2 + 2H2O → NH3 + NH4+ + HCO3-
Due to its high urea concentration, urine is unstable [19]. Complete urea ex-
haustion is completed in a few days only [18] and total ammonia represents 90%
of the nitrogen in stored urine [3]. The hydrolysis of urea causes a pH increase
from pH 6 until around pH 9 [9]. This increase in pH has several consequences:
• The pKa of ammonia is 9.24, therefore at pH 9 the concentration of am-
monia NH3 is high (33-37%) [7, 20]. As ammonia NH3 is volatile, losses
can occur during transportation (agitation) or direct application as fertil-
izer [21]. NH3 evaporation can also be detrimental to environment and
human health [3, 5].
• High pH values trigger precipitation of calcium phosphate, struvite and
calcite [21]. The precipitation of calcium phosphate lowers the available P
concentration in urine, which is undersirable if the urine is to be used as
fertilizer.
The stabilisation of urine is therefore necessary in order to prevent ammonia
volatilisation and convert ammonia into a less volatile form, to reach the goal
of nutrient recovery. There are two options to stabilise urine: acidification
or biological nitrification [7]. pH in the collection tank should be below 4 to
prevent urea hydrolysis [9]. Acidification is an efficient method and such low pH
value has an adverse effect on pathogens. However, it is a costly method due to
the use of chemicals, and as ureolysis is a fast reaction, the technical realisation
is complicated [8].
Biological nitrification is a suitable method for urine stabilisation. It prevents
ammonia evaporation, but also the strong urine odour [9]. Nitrification involves
two groups of nitrifying bacteria: ammonia oxidising bacteria (AOB) and nitrite
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oxidising bacteria (NOB). AOB oxidise the ammonia to nitrite and NOB oxidise
nitrite into nitrate. The nitrification reaction is divided in two steps:
1. Ammonia oxidation : NH3 + 1.5 O2 → NO2- + H+ + H2O
The first step is actually divided into two steps where hydroxylamine
(NH2OH) is the intermediate product.
2. Nitrite oxidation : NO2- + 0.5 O2 → NO3-
Nitrification lowers the pH to around 6. As half of the NH3 can be oxidised, the
remaining NH3 is converted to NH4+, which is non volatile. Udert et al. tested
different types of reactor: a moving bed biofilm reactor (MBBR), a continuous
flow stirred reactor (CSTR) and a sequencing batch reactor (SBR) [21]. In all
cases the maximal conversion of ammonia into nitrate was of 50%. Apparently
ammonia oxidation does not occur at pH values far below 6 [21]. Biological nitri-
fication requires a good coordination between AOB and NOB, which is difficult
to maintain especially because source-separated urine is a difficult environment
for nitrifying bacteria. The parameters influencing nitrification are listed in the
table below (Table 1):
Table 1: Parameters influencing nitrification (adapted from [3])
Parameter AOB NOB
Oxygen Higher affinity to oxygen Lower affinity to oxygen
Temperature Faster inscrease with T° Slower increase with T°
Substrate inhibition and
limitation
Substrate for AOB = am-
monia NH3
Substrate for NOB = ni-
trous acid (HNO2)
Product inhibition Strongly inhibited by HNO2 N03 inhibition usually neg-
ligible
Inhibition by intermediates Inhibition by NH2OH, the
intermediate of ammonia
oxidation
pH is a main parameter for AOB and NOB activity, as the concentration of their
substrate depend on the pH: (NH3/NH4+) for AOB, (HNO2/NO2-) for NOB,
with pKa=9.25 and 3.29 respectively [21]. High pH fluctuations can break down
the process, and high pH values have more sever consequences. The pH must
therefore be carefully regulated [21].
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2.2 Pathogens
2.2.1 Viruses
Viruses are microorganisms that can infect all kinds of living organisms. They
have their own genome, but are not dynamic systems and depend on the me-
chanical system of their host cell for replication. Replication can be damaging
for the host cell, which is why viruses can be pathogenic [22].
There are various type of viruses: single- or double-standed RNA, positive-
or negative-sense RNA ((+/-)ss-RNA, (+/-)ds-RNA), and single- or double-
stranded DNA (ss-DNA, ds-DNA), which confer different replication strategies.
There are different types of virus structure (size, morphology, chemical composi-
tion), but in all cases the nucleic acid is protected by a protein coat called capsid.
This structure permits the virus to survive in the environment for long periods.
Some viruses have in addition a membrane structure, or envelope. Viruses are
amongst the smallest organisms, tens to hundreeds of nm in size (Fig.2) and are
infective at low dose [23].
Figure 2: Size of different organisms [2]
Heterogeneity and infectivity of viruses make them an important matter of con-
cern in sanitation. Viruses are important enteric pathogens, therefore of major
public health concern, especially in developing areas.
In order to study the behaviour of viruses in nitrification reactors, three different
bacteriophages were used. Bacteriophages are often used in studies as surrogate
for human viruses because of their similar structure. Additionally they are safe
and easier to manipulate than human viruses [24].
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MS2
MS2 is a (+)ss-RNA bacteriophage infecting Escherichia Coli. It has a genome of
3569 bases, an icosahedral symmetry [25], a diameter of 26nm and an isoelectric
point of 3.9 [26]. MS2 has a similar structure to enteric viruses. It is known to
be more hydrophobic than the bacteriophage ΦX147 [10].
Qbeta
Qbeta is a (+)ss-RNA bacteriophage infecting Escherichia Coli. It has a genome
of 4217 bases [27], an icosahedral symmetry [28], a diameter of 24nm and an
isoelectric point of 5.3 [26]. It has a similar structure and size to bacteriophage
MS2, thus they are expected to have similar behaviours.
ΦX147
ΦX147 is a ss-DNA bacteriophage, infecting Escherichia Coli. It has a genome
of 5386 bases [22], a icosahedral symmetry [29], a diameter of 27nm and an
isoelectric point of 6.6 [26]. ΦX147 may be a relatively conservative model virus,
because of its low hydrophobicity and high stability [30].
2.2.2 Bacteria
Bacteria are prokaryote microorganisms. Ranging in size from 0.2-2µm in width
to greater than 50µm in diameter [22] (see Fig.2). In general, small cells grow
faster than large cells. This is a reflection of their large surface to volume ratio
that allows a rapid exchange with the external environment.
The diversity in the Bacteria domain is very large. However, they can be distin-
guished as gram-positive or -negative cells which indicates differences in the cell
wall structure [22]. Bacteria have a rigid cell wall: gram-positive bacteria have
a thick peptidoglycan layer, while gram-negative bacteria have a thin peptido-
glycan layer and an outer membrane composed of lipopolysaccharide and protein
[22]. The vulnerability of gram-positive and –negative bacteria differs according
to this variation in membrane composition and structure.
Enteric bacteria (e.g. Clostridium difficile , Salmonella enterica), responsible for
various diseases, are of concern in sanitation. They cause infections, gastroen-
teritis, and can have lifethreatening consequences.
In order to study the behaviour of bacteria in nitrification reactors, two different
bacteria, one gram-negative and one gram-positive were used.
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Enterococci
Enterococcus is a gram-positive bacteria. Enterococci are facultative anaerobic
organisms that can survive and grow in many environments [22]. Enterococcus
faecalis and Enterococcus faeciumare are two human pathogens frequently found.
They are responsible for infections, endocarditis and scepticemy and are also
commonly used as indicators of faecal pollution in the environment.
Salmonella
Salmonella is a gram-negative bacteria. It is sensitive to acidic pH [22].
Salmonella are generaly pathogenic for human beings, causing gastroenteritis
and typhoid fever.
2.2.3 Potential inactivation mechanisms
Pathogenic organisms such as bacteria and viruses are exposed to different in-
activation mechanisms. Virus inactivation is particularly complicated to antic-
ipate. Indeed, two highly related viruses treated with the same biocide can
follow different inactivation kinetics [31]. Although little is known about inacti-
vation of pathogens during nitrification, several parameters are known to influence
pathogens inactivation in other conditions.
Air-water interface
Thompson et al. studied the inactivation of bacteriophages MS2 and ΦX147
by air-water interface (AWI) [29]. They proposed that viruses in solution reach
the AWI, via convection and diffusion, where they adsorb. The adsorption is
controlled by several factors (electrostatic, hydrophobic and hydration forces;
solution ionic strength; pH; and other). At the AWI, hydrophobic regions of the
virus capsid partition out of the solution into the gas phase via reconfiguration
of the capsid proteins, resulting in the loss of infectivity [29]. The location of
inactivation is more exactly at the triple-phase-boundary (TPB), i.e. the interface
between air, liquid and solid, rather than at the AWI [29]. The inactivation is
therefore influenced by the hydrophobicity of the solid phase [29, 32] . As the
step of adsorption depends on the surface properties of the virus [33], different
inactivation efficiencies are expected. Also, viruses containing hydrophobic parts
are more sensitive to AWI inactivation, because these parts tend to be located in
the air phase [32, 33]. In their study, bacteriophage MS2 revealed to be subject
to inactivation by AWI, but ΦX147 was apparently not affected [29].
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As the nitrification reactors are aerated, the AWI is continuously regenerated,
renewing the location for virus inactivation. Also the composition of the reactor
wall, whether it is made of hydrophobic or hydrophilic material, could influence
the inactivation efficiency. The presence of biofilm carriers (which are the support
for nitrifying bacteria growth) made of polyethylene (PE), a hydrophobic material,
in the reactors is to be remembered. Their contribution to the inactivation would
probably be inversly proportional to the amount of biofilm attached, so directly
proportional to the surface of PE remaining.
Ammonia concentration, pH and temperature
Free ammonia (NH3), pH and temperature are the three key parameters of urine
storage. Inactivation of pathogens in stored urine has been the subject of various
studies [6, 10, 14, 34, 35]. Stored urine presents hard conditions: high NH3
concentrations and high pH. NH3 is a known biocide for most organisms as are
high pH values [36]. Several studies have demonstrated that the survival rate
of pathogens is low at high temperatures [34, 35]. Gram-negative bacteria are
more rapidly inactivated in stored urine than gram-positive bacteria and viruses
were the most persistant group [6].
In this study, NH3 in the reactors is oxidised and pH is lowered by the nitrifi-
cation, and the temperature is not controlled. Therefore the conditions are less
threatening to pathogens than in stored urine. However, localised inactivation
might happen to the place where urine enters the reactor.
Effect of biological treatment system
Activated sludge in wastewater treatment systems is capable of removing viruses
by physicochemical and biological processes [37]. The virus can be adsorbed
on the sludge floc [37], or the sludge microbes can ingest it [38]. Kim et al.
demonstrated that the inactivation of virus is efficient during the first hour of
contact and that adsorption of virus onto bacteria is reversible. Floc-forming
bacteria have a higher capability of decreasing virus infectivity than non-floc
forming bacteria [37].
Other virucidal and bacteriocidal parameters are described in the literature, but
did not seem relevant for this study.
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Tailing phenomenon
In addition to the potential inactivation effects listed above, a nitrification
system can provide protection to pathogens. Sigstam et al. studied the
tailing phenomenon during virus disinfection [31], in which the inactivation rate
decreases over time. The virus can be protected by deposition of an adduct on
the capsid protein. This deposition can be removed by washing, therefore the
protection is reversible [31].
Nitrified urine is a complex solution, it is thus possible to expect deposition of
urine constituents on the virus in this study.
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3 Set-up, materials and methods
Two types of nitrification reactors were operated in this study: two main continu-
ous flow moving bed biofilm reactors (MBBR) and several batch and semi-batch
reactors.
The two continuous flow moving bed biofilm reactors (MBBRs) were run in par-
allel. After ensuring the stability of the reactors, one of the reactors (Reactor no.
2) was spiked continuously with bacteriophage MS2. The other continuous flow
reactor (Reactor no. 1) remained clean of tested bacteriophage and bacteria.
A series of batch and semi-batch MBBRs, of smaller volume than the continu-
ous flow reactors, were set-up to test several bacteriophages and bacteria under
varying experimental conditions. These batch and semi-batch reactors were fed
with the content of the continuous flow Reactor no. 1 (biofilm carriers, nitrified
urine).
3.1 Continuous flow MBBRs
Free suspended biomass processes are known to be efficient with fast growing
organisms that have a short residence time. In the case of slow growing organ-
isms, such as nitrifiers, retention or recirculation of biomass is required. Biofilms
effectively retain biomass in the reactor and improve the volumetric conversion
capacity [39]. Moving bed biofilm reactors are reactors where the biofilm grows
on small particles, the carriers, that are mobile in the reactor. The advantages of
this process are an enlargement of the biofilm specific area, a higher volumetric
substrate conversion and a higher oxygen transfer rate. The Kaldnes® carriers
were used in the MBBRs and their characteristics are listed in the table below
(Table 2):
Table 2: Kaldnes® carriers characteristics
Technical specification Kaldnes®
Material Polyethylene
Specific surface area 460 m2/m3
Maximum fill 30% to 65%
Weight per m3 152 kg/m3
Surface per unit 4.68 cm2
Percentage of hollow space 93%
The specific parameters for operating continuous flow MBBR were determined
by research led at Eawag on nitrification reactors.
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3.1.1 Continuous flow MBBR set-up
The main components of a continuous flow reactor are (see Fig.3):
1. Influent tank: filled with stored urine
2. Eﬄuent tank: receives overflow from reactor
3. Reactor: filled with Kaldnes® carriers (50% of volume) and nitrified urine
(to full volume). Each reactor has a capacity of 7 L.
4. pH transmitter
5. Peristaltic pump: controlled by the pH transmitter
6. Dissolved oxygen (DO) transmitter
7. pH and dissolved oxygen probes: fixed at the top of the reactor.
8. Data logger: records continuously pH and DO values
9. Aeration device
Table 3: Reference for material used for continuous flow MBBRs
pH transmitter Liquisys M CPM223/253 Endress + Hauser
DO transmitter Liquisys M COM223F/253F Endress + Hauser
Data logger Ecograph TRSG35 Endress + Hauser
pH probe ISFET, CPS 491 Endress + Hauser
The reactor spiked with bacteriophage MS2 had supplementary components (see
Fig.4):
10. Syringe pump and syringe: the syringe contains the solution of MS2. The
syringe pump discharges the solution continuously in the reactor
Initial set-up
Urine for the nitrification experiments was collected from the men’s NoMix stor-
age tank at Eawag’s main building. 100L were fetched on September 10, 2013,
transported by car in 50L containers, and subsequently stored at 4°C. Nitrified
urine (appr. 25L) and Kaldnes® carriers with biofilm already grown (appr. 10L)
were collected from the operating nitrification reactor at Eawag. They were
stored at 4°C until the reactors were launched (October 1-3, 2013).
pH regulation
The pH within the reactors is controlled by urine input. The pH transmit-
ter is configured to regulate the pH within the reactor, with a PID regulation
(proportional-integral-derivative). The pH transmitter records the instant pH
value of the reactor and activates the perisaltic pump that injects stored urine in
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Figure 3: Continuous flow MBBR set-up. 1: Influent tank, 2: Eﬄuent tank, 3: Reactor, 4:
pH transmitter, 5: Peristaltic pump, 6: DO transmitter, 7: pH and DO probes, 8:
Datalogger (not present in the picture), 9: Aeration device
Figure 4: Reactor no. 2, with 10: syringe pump and syringe
the reactor when needed. Based on the work on nitrification reactors at Eawag,
the target lower and upper pH limits in the reactor are pH 6 and 6.1. In this
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study, a proportional regulation (P) was used to control the urine input, meaning
that the action of the regulator is proportional to the difference between the
measured value and the target value. The parameters (Kp, tmin) were empirically
determined to have a rapid reaction, but without an overshoot of the set-point:
• pH set-point = 6.1
• Kp = 3 : proportional gain. It determines the response time.
• Tmin = 0.1s : minimal length of response. This length should allow at
least one drop of urine in the reactor.
With these values, the average pH in the reactors stayed stable at 6.05
(S.D.<0.0001) throughout the entire sampling period, except for short periods of
electronic malfunction. The P regulation allows a gentle approach of the target
value, avoiding sudden pH changes.
Aeration Compressed air was diffused from the bottom of the reactor to
ensure the aeration of the reactor and the mixing of the carriers. An air diffuser
(bought in Qualipet store) was fixed at the bottom of a plastic rod, which was
secured against the wall of the reactor. The compressed air went first through
an empty bottle to avoid backwash in the compressed air supply system, then
through a bottle filled with water in order to moisturise the air before entering
the reactor.
The open parts at the top of the reactors were clogged with paper towel to avoid
too much evaporation and escape of foam from the reactor.
Maintenance
The pH and DO probes were calibrated weekly, according to the manufacturer
instructions.
Monitoring
The weights of the influent and eﬄuent tanks were recorded daily. In case of
sampling, the amount, date and time were recorded. When nitrified urine and
Kaldnes® were removed from the reactor for other experiments, the same volume
of material was replaced, using the stock stored at 4°C.
The data logger recorded the values of pH and DO in each continuous flow re-
actor at a frequency of one data-point per minute.
Temperature was recorded daily, based on the value displayed by the pH trans-
mitter.
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3.2 Batch and semi-batch MBBRs
In order to be able to test several types of pathogens as well as different pa-
rameters (such as aeration, composition of solution, etc.), small semi-batch and
batch reactor tests were conducted. The volume of these reactors was more than
10 times smaller than the continuous flow MBBRs volume. Faster results could
be obtained that way.
3.2.1 Batch and semi-batch set-up
Two sets of experiments with different types of reactor were conducted:
• semi-batch: input, no output, with aeration
• aerated batch: no input, no output, aeration
• non-aerated batch: no input, no output, no aeration
The main components of the set-up are (see Fig.5):
1. Batch or semi-batch reactor: 1L glass bottle, filled with carriers, previously
sieved (250mL) and solution (500mL) as specified in Table 4.
2. Influent bottle: 1L glass bottle
3. Multichannel peristaltic pump
4. Aeration device
Figure 5: Batch and semi-batch MBBR set-up. 1 & 2: Reactors and influent bottles, 3:
Multichannel peristaltic pump, 4: Aeration device
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Initial set-up
Nitrified urine and biofilm carriers were collected from the operating continuous
flow Reactor no. 1. Clean carriers (non-sterile) given by the Laboratory for
Environmental Biotechnology (EPFL), were used in control batches (see exact
composition in Table 4).
pH regulation
pH was not recorded constantly. The urine input flowrate was determined em-
pirically by a previous test. Regular pH controls and nitrite strip tests allowed to
check the batches stability.
Aeration
Compressed air was diffused from the bottom of the reactor to ensure the aeration
of the reactor and the mixing of the carriers. An air diffuser was wedged against
the wall of the reactor. The compressed air went first through an empty bottle
to avoid backwash in the compressed air supply system, then through a bottle
filled with water in order to moisturise the air before entering the reactor.
The open parts at the top of the reactors were partially covered with parafilm to
avoid contamination and too much evaporation.
Filtration
Filtered nitrified urine was used for some of the batch MBBRs (see Table 4). Ni-
trified urine was filtered first with a 0.7µm glass fiber filter (1825-047, Whatman)
and subsequently with a 0.45µm cellulose nitrate filter (NC 045 50 BL, Albet
LabScience), previously rinsed with 50mL of phosphate buffer saline (PBS).
As mentioned above, the batch and semi-batch reactors were used to assess the
effect of different parameters on various pathogens in a short amount of time.
To this extent, five types of reactors were prepared (Table 4).
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Table 4: Composition of batch and semi-batch reactors
Type Name and purpose Composition
1
Nitrified urine 1 and 2
500mL nitrified urine (from Reactor no. 1)
250mL biofilm carriers (from Reactor no. 1)
average pH measured = 6.2
Biologically active batch aerationinput = stored urine
2
Filtered nitrified urine
500mL nitrified urine (from Reactor no.1) filtered at 0.45µm
250mL clean carriers (LBE, EPFL)
average pH measured = 6.1
Sterile control aerationinput = nitrified urine filtered at 0.45µm
3
PBS, aeration
500mL phosphate buffer saline (PBS)
250mL clean carriers (LBE, EPFL)
pH controlled = 6.1
Simple matrix composition aerationno input
4
PBS, no aeration 500mL PBSpH controlled = 6.1
Room temperature and AWI reference no aerationno input
5
Nitrified urine, no aeration 500mL nitrified urine (from Reactor no. 1)pH controlled = 6.1
Room temperature and AWI reference no aerationno input
Several inactivation mechanisms and inactivation influencing factors were esti-
mated based on the following comparisons:
• Reproducibility: type 1 semi-batch is the closest replication of the con-
tinuous flow nitrification reactors. Two semi-batches of type 1 were run in
parallel to asses the reproducibility of the measurements.
• Effect of biological treatment system: the comparison of type 1 and 2
semi-batches (Table 4) reveals the effect of the presence of nitrifying bac-
teria and nitrification reaction. Indeed, type 1 semi-batch composition is
similar to the continuous flow MBBRs, while type 2 semi-batch undergo the
same variation (solution input, temperature, ...) but contain no nitrifying
bacteria (filtered solution and clean carriers).
• Air-water interface: the comparison of batches type 3 with 4, and type
1 with 5 should indicate whether the aeration, therefore a great air-water
interface influences the die-off rate of bacteriophages and bacteria. Two
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different solution compositions were assessed for this mechanism (nitrified
urine, PBS).
• Tailing phenomenon, solution composition: the comparison of re-
actors type 1, 2 and 3 (two complex solutions and one simple solution)
reveals whether the inactivation of pathogen indicators is affected by the
composition of solution in aerated systems.
• Room temperature: if inactivation in batches types 1 to 3 is noticed,
the effect of the room temperature on the survival of bacteria and bacte-
riophages needs to be known. Batches of type 4 and 5 were spiked with
pathogen indicators and left in the same room as the other reactors, cov-
ered but not sealed. They can be used as reference. If the inactivation
observed in the other batches is exactly the same as this reference, the
exposure of the indicators to room temperature might be the cause of
the die-off. Otherwise the presence of another inactivation mechanism is
implied.
3.3 Analytical methods
3.3.1 Chemical solutions
PBS: Virus and bacteria experiments were conducted using phosphate buffer
saline (PBS: 5mM PO42-, 10 mM NaCl, pH 7.5).
Beef extract: Beef extract (Merck) 6% containing glycine (pH 9.3) was used
for a method developpment and for a desorption test.
3.3.2 Sampling
Monitoring of continuous flow reactors
Frequency: Ammonium, nitrate, nitrite, total-nitrogen and COD were moni-
tored periodically with cuvette tests. Over the period of this study (September
2013 to December 2013), 10 measurements were taken.
Methodology: For each measurement the following quantities were sampled:
• Influent: 18mL removed (two times 9mL) from the influent tank with a
sterile 10mL syringe.
• Eﬄuent: 18mL pipetted (two times 9mL) directly from the reactor content
with a sterile 10mL pipette.
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Hach and Dr.Lange cuvette tests: Kit tests from the manufacturer Hach-
Lange were used to measure the following parameters in the nitrification reactors:
Table 5: Hach and Dr.Lange kit test references
Parmeter Dr. Lange kit reference
Ammonium LCK 303
Nitrite LCK 342
Total Nitrogen LCK 338
Chemical oxygen demand (COD) LCK 614
Samples analysed with the Dr.Lange kits were previously filtered using a 0.45µm
•cellulose nitrate filter (NC 045 50 BL, Albet LabScience). The first 9mL of
the filtrate were discarded to avoid modification in nitrogen concentration due
to the filter composition. Samples analysed were diluted with Milli-Q water.
Ion chromatography was used to analyse anions and cations in the nitrification
reactors. However, due to technical issues, the data collected are not reliable
enough, and will not be represented in the results.
Monitoring specific to the spiked continuous flow Reactor no. 2
MS2 spiking started on November 1st, 2013.
Frequency: Samples of the reactor content and syringe input reference were
taken almost daily.
Methodology: A 1mL sample was pipetted directly from the reactor content,
with a sterile 5mL pipette. All samples were taken in duplicates.
Input syringe: The syringe input solution had a concentration of 107 pfu/mL
(±12%). To avoid possible decrease in bacteriophage concentration due to the
exposure at room temperature, the input solution was renewed every 2 or 3 days.
At each renewal, 0.5mL of the input solution was reserved in an eppendorf, and
placed besides the Reactor no. 2, i.e. under the same temperature conditions.
This solution was used as reference to assess the concentration in the syringe.
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Monitoring of batch and semi-batch MBBRs
Frequency: Samples of were taken daily.
Methodology: A 1mL sample was pipetted directly from the reactor content,
with a 5mL sterile pipette.
3.3.3 Bacteriophage enumeration
MS2
Bacteriophage MS2 (DSMZ 13767) and its Escherichia Coli host (DSMZ 5695)
were used. The stock of MS2 was produced according to the method described in
Pecson et al. [24]. The stock was conserved in PBS at 4°C. The E. Coli host was
conserved in aliquots at -80°C, and was grown overnight at 37°C in streptomycin-
containing LB broth immediately prior to use in batch experiments. The method
of double-layer agar was used for enumeration [40].
ΦX147
Bacteriophage ΦX147 (DSMZ 4497) and its Escherichia Coli host (DSMZ 13127)
were used. The stock of ΦX147 was produced according to the method described
in Pecson et al. [24]. The stock was conserved in PBS at 4°C. The E. Coli
host was conserved in aliquots at -80°C, and was grown overnight at 37°C in
streptomycin-containing LB broth immediately prior to use in batch experiments.
The method of double-layer agar was used for enumeration [40].
Qbeta
Bacteriophage Qbeta (DSMZ 13768) and its Escherichia Coli host (DSMZ 5695)
were used. The stock of Qbeta was produced according to the method described
in Pecson et al. [24]. The stock was conserved in PBS at 4°C. The E. Coli
host was conserved in aliquots at -80°C, and was grown overnight at 37°C in
streptomycin-containing LB broth immediately prior to use in batch experiments.
The method of double-layer agar was used for enumeration [40].
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3.3.4 Bacteria enumeration
Salmonella
Salmonella typhimurium (M 1414) isolates grown on LB agar containing 100
µg/ml ampicillin were provided by the Environmental microbiology group at
Eawag, grown in LB broth with 100 µg/ml ampicillin, and stored in aliquots with
15% glycerol at -80°C. Salmonella from stored aliquots were grown overnight in
ampicillin-containing LB broth immediately prior to use in batch experiments.
100µL of sample were plated using the spread-plate method on agar for enumer-
ation.
Enterococci
Enterococcus spp. (ENT) colonies were isolated from wastewater treatment
plant influent on Bile Esculin Agar (Sigma Aldrich) and subsequently grown
in Azide Glucose Broth (Sigma Aldrich). Aliquots of log-phase growth ENT
were stored at -80°C with 15% glycerol. ENT from stored aliquots were grown
overnight in azide glucose broth immediately prior to use in batch experiments.
100µL of sample and 50mL PBS were filtered using the membrane filtration EPA
method 1600 for enumeration.
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4 Results and discussion
4.1 Continuous flow reactors
The two continuous flow MBBRs were launched on October 1st and 3rd, 2013.
The material came from the operating reactor at Eawag, therefore the system
was already at steady state. Several compounds and parameters in the reactors
were regularly measured (see Chapter 3.3.2). The viabilty of a reactor can be
estimated through the nitrification rate, which is calculated as follows:
Nitrification rate [g/m2d ] = (NH4,in[gN/L] ∗ Qin[L/d ])− (NH4,out [gN/L] ∗ Qout [L/d ])Carriers total surface [m2]
Table 6: Average measured nitrification rate in continuous flow MBBRs
Average nitrification rate
Average ± S.D.
Reactor no. 1 [gN/m2d] 0.56 ± 0.14
Reactor no. 2 [gN/m2d] 0.49 ± 0.10
On the graphs below (Fig.6), the pH, DO and temperature data points are
represented along with the nitrification rate. The disturbances represented by the
red bars correspond to high perturbation events in the system. For Reactor no. 1,
each event is a removal of the reactor content (and replacement from the stock
material) for the batches experiments (see Chapter 3.2.1). The long disturbance
in Reactor no. 2 is a period with no urine input, as a parallel experiment required
the pH transmitter, and also because of technical issues.
The nitrification rate decreased over the period of the study in both reactors.
pH and DO were relatively stable. The measurements of temperature were taken
once a day, and at different times of the day. The temperature was in average
lower than the temperature recorded during experiments led at Eawag, which
may have affected the efficiency of the nitrification. The strongest variations
appeared in Reactor no .1, where an important part of the reactor material (2L
of nitrified urine, 1L of carriers) was removed and replaced by stored material.
The important sampling might have had an effect on the stability of the system.
Along with the decrease in nitrification rate, the input and output flowrate de-
creased in both reactors. Again, the phenomenon is more pronounced in Reactor
no. 1 (see Fig.7).
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Figure 6: Continuous flow MBBRs recorded parameters (pH, dissolved oxygen) compared to
nitrification performances. Reactor no. 1 at the top, Reactor no. 2 at the bottom
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Figure 7: Inflow and outflow rates in continuous flows MBBRs. Reactor no .1 at the top,
Reactor no. 2 at the bottom
The evolution of the MBBRs was followed by chemical analysis of the system.
The concentrations measured in stored urine (Table 7) are consistent with other
analysis of urine from the NoMix men’s storage tank at Eawag [8, 10].
Table 7: Average stored urine measured parameters in continuous flow MBBRs (n=8)
Stored urine, Reactor no. 1
Average ± S.D.
NH4 tot [mg/L] 3764 ± 182
N tot [mg/L] 3973 ± 436
COD [mg/L] 3870 ± 61
COD/N [mg O2/mg N] 1.04 ± 0.12
pH [-] 9.04 ± 0.09
Stored urine, Reactor no. 2
Average ± S.D.
NH4 tot [mg/L] 3573 ± 300
N tot [mg/L] 3780 ± 168
COD [mg/L] 3893 ± 264
COD/N [mg O2/mg N] 1.06 ± 0.08
pH [-] 9.04 ± 0.1
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The values measured within the reactors are shown in Table 8. From compar-
ison with Table 7, we see that half of the total ammonia was oxidised during
nitrification, which is consistent with the literature (see Chapter 2.1). NO3 was
measured by IC, but due to technical issues, the data are not reliable enough to
be represented here.
Table 8: Average eﬄuent measured parameters in continuous flow MBBRs (n=8)
Eﬄuent values, Reactor no. 1
Average ±S.D.
NO2 [mg/L] 1.37 ±0.43
NH4 tot [mg/L] 1980 ± 129
N tot [mg/L] 4273 ±330
COD [mg/L] 419 ±72
COD/N [mg O2/mg N] 0.09 ±0.01
pH [-] 6.05
Eﬄuent values, Reactor no. 2
Average ±S.D.
NO2 [mg/L] 1.27 ±0.30
NH4 tot [mg/L] 1854 ±248
N tot [mg/L] 4253 ±152
COD [mg/L] 401 ±70
COD/N [mg O2/mg N] 0.09 ±0.005
pH [-] 6.05
In general, the two continuous flow MBBRs were operating properly. But after
a certain time the nitrification rate decreased. The exact causes of this decrease
are not fully understood. The removal of material is not the main cause, because
the nitrification rate decreased in both reactors, and material was mostly removed
from Reactor no.1. It may still have a impact on the stability of the reactor, as
nitrification and flowrates in Reactor no. 1 were slower. The dimensions of the
reactors (height, width) and force of aeration could contribute to the difference
with the rates measured in other experiments led at Eawag.
In the table below (Table 9), we can note that the losses by evaporation were
limited. The hydraulic retention time (HRT= V/Q) increased as the flowrate
decreased. The average temperature in the reactors in approximately 5°C lower
than the reported operating reactors temperature in the literature [8].
Table 9: Average continuous flow MBBRs measured parameters
Parameters, Reactor no. 1
Average ± S.D.
HRT [d] 20.7 ± 8.2
Losses [%Vol] 1.1% ± 0.9
Temperature [°C] 19.1 ± 1.8
Parameters, Reactor no. 2
Average ± S.D.
HRT [d] 17 ± 3.7
Losses [%Vol] 1.6% ± 0.9
Temperature [°C] 20.2 ± 1.3
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4.2 Continuous flow reactor spiked with MS2
The continuous flow Reactor no. 2 was spiked continuously with the bacterio-
phage MS2 for 50 days. The concentrations are expressed in plaques forming
unit per mL (pfu/mL).
In a continuous flow reactor, the concentration of a tracer is calculated as follows:
Ctracer [pfu/mL] =
((CR2,t−1[pfu/mL] ∗ VR2[mL]))
VR2[mL]
+(Csyringe[pfu/mL] ∗ Qsyringe[mL/min] ∗∆t[min])VR2[mL]
−(CR2[pfu/mL] ∗ QR2,out ∗∆t[min])VR2[mL]
Where :
• CR2,t−1 = Concentration in the reactor at t = t-1
• VR2 = Volume of reactor
• Csyringe= Concentration of MS2 in syringe
• Qsyringe = Flowrate of discharge of MS2 solution in the reactor
• QR2,out = Discharge out of the reactor
In a continuous flow reactor, the volume is constant. The general mass balance
is: IN - OUT + CONVERSION = 0, as there is no accumulation.
In the equation to calculate the concentration of a tracer, Ctracer , the first term
of the numerator corresponds to the amount already present in the reactor,
divided by the volume of the reactor. The second term is the amount of MS2
discharged in the reactor during a period of time ∆t, divided by the volume of
the reactor. The third term of the equation is the amount of MS2 leaving the
reactor, divided by the volume of the reactor.
Based on this equation, a model based on the Ctracer equation in Excel using
1-minute time steps was used. The steady-state in a CSTR (continuously stirred
tank reactor) is reached after three HRT [41]. The Excel model confirmed that
the period for the tracer to reach a steady state concentration within the reactor
is very long. Injecting at first a high concentration of a tracer in a continuous
flow reactor allows the concentration in the reactor to rise very fast. A lower
concentration can later be spiked. The period of time required to reach the
tracer steady state can be skipped this way.
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This assumption was tested on the Reactor no. 2 by injecting:
• 1010 pfu/mL of MS2 at 0.001 mL/min for 1 hour; followed by
• approximately 107 pfu/mL of MS2 at 0.001 mL/min continuously after this
time.
These concentrations were determined with the Excel model. The values
were manipulated by trial-and-error to establish the target concentration at
steady-state in the reactor within a reasonable timeframe.
In Fig.8, the evolution of MS2 concentration over time is displayed. Based on the
measurements of the MS2 spiking solution (concentration, injection flowrate) and
the reactor monitoring, the concentration of a tracer is calculated (blue line). The
actual sampling results are represented by the red line. To date, the difference
between these concentrations is not significant and MS2 reacts for the moment
as a tracer within the nitrification reactor, suggesting that over the period of this
experiment, the bacterial community in the reactor did not adapt to inactivate
MS2 bacteriophage.
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Figure 8: Evolution of bacteriophage MS2 vs. the concentration of a calculated tracer
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4.3 Batch experiments
Smaller batch reactors avoid the constraint of the time to reach steady-state
mentioned before. Inactivation of bacteriophages MS2, ΦX147 and Qbeta,
as well as the inactivation of bacteria Enterococcus spp. and Salmonella was
tested over 7 to 10 days.
The spiked concentrations were:
• S.typhimurium = 108 cfu/ml
• ENT = = 105 cfu/ml
• MS2 = 106 pfu/ml
• Qbeta = 106 pfu/ml
• ΦX147 = 106 pfu/ml
Concentrations are expressed in plaques forming unit per mL (pfu/mL) for
bacteriophages and in colony forming unit per mL (cfu/mL) for bacteria.
The evaporation in the batches proved more significant with this set-up than
in the continuous flow reactors. The aeration was difficult to adjust to the size
of the batch reactors. Another difference with the continuous flow MBBRs is
that the semi-batch MBBRs do not have an outflow, so the volume rises. The
calculated concentrations were adapted to the evaporation and the input.
In the batches containing nitrifying bacteria, pH and nitrite concentrations were
measured daily to verify the batch reactors stability. pH values were stable
around 6.2 and there was no nitrite accumulation.
The following graphs display the fraction of surviving organisms (C/C0) over
time, C0 being the initial spiked concentration.
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4.3.1 Inactivation of bacteriophages
Reproducibility (Fig.9) The reproducibilty was assessed by comparing the re-
sults of the two semi-batches of "type 1" that are the closest representation of the
continuous flow nitrification reactors (see Table 4). Fig.9 shows that the repro-
ducibility between two batches was strong for each of the three bacteriophages.
Two-tailed t-test assuming equation variance was calculated for the three bacte-
riophages experiments by comparing the full data set of batch 1 to that of batch
2 for each organism: ΦX147 (p=0.84), MS2 (p=0.77), Qbeta (p=0.71).
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Figure 9: Reproducibility of inactivation of bacteriophage (ΦX147, MS2, Qbeta) in semi-
batch nitrification MBBR
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Effect of biological treatment system (Fig.10) Semi-batches containing
an operating nitrification system (type 1 in Table 4) were compared to sterile
controls, semi-batches containing filtered nitrified urine, i.e., no bacteria larger
than 0.45µm (type 2 in Table 4). The composition of the solution is complex in
both cases and the same conditions were applied (input of solution, either urine
or filtered nitrified urine).
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Figure 10: Effect of nitrification in semi-batch MBBR on the inactivation of bacteriophage
(ΦX147, MS2, Qbeta)
For each phage, the concentration of bacteriophage followed the same evolution,
regardless of the batch type (active biological system or sterile control). This
result indicates that the biological activity in the nitrification reactors does not
cause bacteriophage inactivation.
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Air-water interface (Fig.11 and 12) The air-water interface influence was
evaluated by comparing inactivation in aerated and non-aerated systems, in
both PBS (Fig.11) and nitrified urine (Fig.12), corresponding to a comparison
between batches of type 3 and 4 and of type 1 and 5 from Table 4, respectively.
In the buffer, a strong inactivation of ΦX147 was observed in the batch in the
presence of aeration. A second test in buffer with aeration was conducted to
confirm this decrease, but in this second test, the concentration remained stable
(Fig.11, ΦX147: PBS, aeration 2). The result of either tests in PBS aerated
could be an isolated event. It would be interesting to repeat this test to confirm
the result.
The aeration seemed to have an inactivation effect on Qbeta in PBS. MS2 was
not disturbed at all. The interpretation for ΦX147 is difficult due to the results
mentioned above.
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Figure 11: Effect of air-water interface on inactvation of bacteriophage (ΦX147, MS2,
Qbeta) in PBS
Based on the results of the repeated test of ΦX147 in buffer (aerated batch)
duplicates of the experiments with all three bacteriophages are recommended.
32
0 2 4 6 8 10 12
10−6
10−4
10−2
100
102
PhiX147
Time [days]
In
fe
ct
ive
 fr
ac
tio
n 
(C
/C 0
)
 
 
0 2 4 6 8 10 12
10−6
10−4
10−2
100
102
MS2
Time [days]
In
fe
ct
ive
 fr
ac
tio
n 
(C
/C 0
)
0 2 4 6 8 10 12
10−6
10−4
10−2
100
102
Qbeta
Time [days]
In
fe
ct
ive
 fr
ac
tio
n 
(C
/C 0
) PhiX147: Nitrified urine, no aeration
PhiX147: Nitrified urine 1, aeration
PhiX147: Nitrified urine 2, aeration
MS2: Nitrified urine, no aeration
MS2: Nitrified urine 1, aeration
MS2: Nitrified urine 2, aeration
Qbeta: Nitrified urine, no aeration
Qbeta: Nitrified urine 1, aeration
Qbeta: Nitrified urine 2, aeration
Figure 12: Effect of air-water interface on inactvation of bacteriophage (ΦX147, MS2,
Qbeta) in nitrified urine
In nitrified urine, neither ΦX147 nor MS2 were affected by the aeration. The
concentration of Qbeta in nitrified urine without aeration decreased importantly
and went even lower than that concentration in aerated nitrified urine. Therefore,
the inactivation of Qbeta could not be explained by aeration alone. Duplicates of
the experiments with Qbeta in nitrified urine without aeration are recommended.
The comparison of the batches with nitrified urine with and without aeration was
meant to highlight the effect of the aeration in a complex media. Nevertheless,
the interpretation is difficult due to the presence of nitrifying bacteria in both
types of batch, but under different conditions: in the first type of batch (aerated),
nitrifying bacteria are grown in biofilm on the carriers and the system receives
urine by input, therefore there is an active nitrification; whereas in the second
batch (non aerated) nitrifying bacteria are in suspension and there is no urine
input.
33
Matrix effect (Fig.13) Batches containing PBS (type 3, Table 4) were
compared to nitrified urine (type 1, Table 4) and filtered nitrified urine (type
2, Table 4) which are two complex solutions. All batches compared were aerated.
Based on the results displayed in the graphs below, one can conclude that in the
complex solutions (nitrified urine and filtered nitrified urine) the inactivation of
bacteriophage is either the same or even less pronounced than in the buffer. This
phenomenon might be due the protective effect of the solution and the tailing
phenomenon described above (Chapter 2.2.3), that would result in the protection
of the bacteriophage.
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Figure 13: Effect of composition of solution on inactvation of bacteriophage (ΦX147, MS2,
Qbeta) in aerated systems
As a plateau was observed in the Qbeta batches, a test was conducted to see
if despositions on the capsid were the cause of the decrease in inactivation.
According to the method described by Sigstam et al. [31], the bacteriophage
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was washed, spiked in a new solution. The concentration spiked should follow
a new inactivation curve. Unfortunately, because the concentration of Qbeta
remaining in solution was low, the volume of washed solution was not large
enough to properly conduct the experiment, and no result could be obtained.
The inactivation curve observed for Qbeta in nitrified urine can be divided into
the exponential decrease and the plateau. The rate constants k were calculated
for the exponential decrease:
Table 10: Inactivation rate constants k for first step of inactivation of Qbeta in nitrification
semi-bacth MBBR, n=4
Nitrified urine semi-batch 1 Nitrified urine semi-batch 2
k = 1.344 [d-1] (R2 = 0.76) k = 1.290 [d-1] (R2 = 0.71)
The monitoring was done daily, so by taking only the first part if the inactivation
the number of samples is limited.
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Room temperature (Fig.14) Viruses are affected by temperature and the
exposure to room temperature of the bacteriophages over the period of time of
the tests might have had an influence on their inactivation.
In order to estimate the proportion of inactivation due to the temperature,
batches with PBS and nitrified urine without aeration (type 4 and 5, Table
4) were installed in the same room as the other batches. The batches were
not completely closed, to be in the same condition as the other batches. The
temperature in the LCE laboratory at EPFL is 20°C.
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Figure 14: Effect of room temperature on inactvation of bacteriophage (ΦX147, MS2,
Qbeta) in non-aerated systems
Bacteriophages ΦX147 and MS2 were not affected by the ambient temperature
over 8 days. The concentration of Qbeta decreased of five log in nitrified urine
over 8 days, but remained relatively stable in PBS. The presence of nitrifying
bacteria in nitrified urine might contribute to this decrease. This measurement
should be repeated to confirm the result.
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Adsorption on the biofilm carriers An assessment of the adsorption on the
carriers permitted to estimate whether the observed inactivation of the bacte-
riophages could be partially due their adsorption the plastic carriers. A two-step
desorption test was conducted. One carrier was placed in 15mL PBS and shaken
vigorously for 2 minutes. The carrier was then placed in 15mL of beef extract
and mixed for 20 minutes. The PBS and beef extract were plated to calculate
the desorption. In parallel, the amount of liquid retained in the void of a carrier
unit was estimated by drying 10 carriers separately. Half of the carriers tested
contained a large amount of biofilm grown on them, and the other half was al-
most free of biofilm.
The recovered concentration from the desorption method corresponded to the
concentration due to liquid retained by the carrier. This parameter can therefore
be ruled out for bacteriophages. The test was not conducted for bacteria.
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4.3.2 Inactivation of bacteria
Reproducibility (Fig.15) The curves of inactivation of Enterococcus spp.
(ENT) and S.typhimurium were similar between two identical batches (type 1,
Table 4). Two-tailed test (ttest) assuming equation variance was calculated for
the two bacteria: S.typhimurium (p=0.996) and ENT (p=0.943).
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Figure 15: Reproducibility of inactivation of bacteria (ENT, S.typhimurium) in semi-batch
nitrification MBBR
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Effect of biological treatment system (Fig.16) The concentrations of ENT
and S.typhimurium were stable in the absence of bacteria, i.e. in filtered nitrified
urine (batce type 2, Table 4). On the contrary, in nitrification batches (batch
type 1, Table 4) the inactivation was clear and reached a 3-log inactivation for
ENT and a 5-log inactivation for S.typhimurium.
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Figure 16: Effect of nitrification in semi-batch MBBR on the inactivation of bacteria (ENT,
S.typhimurium )
Biological activity appeared to have an effect on the survival of bacteria. The
difference between the two types of batches was clear.
The inactivation rate constants k in both type 1 semi-batch reactors were calcu-
lated:
Table 11: Inactivation rate constants k for inactivation of S.typhimurium and ENT in bio-
logically active reactors
Nitrified urine semi-batch 1 Nitrified urine semi-batch 2
S.typhimurium k = 0.570 [d-1] (R2 = 0.85) k = 0.665 [d-1] (R2 = 0.82)
ENT k = 0.400 [d-1] (R2 = 0.91) k = 0.400 [d-1] (R2 = 0.83)
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Air-water interface (Fig.17) Batches containing nitrified urine and PBS were
compared with and without aeration.
It is important to note that the batch containing nitrified urine without aeration
did not contain carrier and was not fed by urine. Nevertheless, nitrifying bacteria
were present in suspension. On the other hand, the batch aerated with nitrified
urine was set-up as a nitrification reactor, with urine input and biofilm grown
on the carriers. The comparison is still interesting in order to asses the effect of
bubbling.
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Figure 17: Effect of air-water interface on inactvation of bacteria (ENT, S.typhimurium) in
PBS and nitrified urine
Based on the graphs in Fig.17, the aeration did not affect the inactivation of
bacteria neither in PBS nor in nitrified urine, as all the slopes followed the same
path.
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Matrix effect (Fig.18) Fig.18 shows the comparison of inactivation in an
aerated system in a simple solution (PBS) and in complex solutions (nitrified
urine and filtered nitrified urine). The concentration of ENT stayed unchanged
in filtered nitrified urine and PBS, but decreased in nitrifed urine (nitrification
batch). S.typhimurium reacted in a similar way.
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Figure 18: Effect of composition of solution on inactvation of bacteria (ENT, S.typhimurium)
in aerated systems
The complexity of the solution did not protect bacteria as it could do for bacte-
riophage. The difference in inactivation in Fig.18 seemed to be due to the bio-
logical activity in semi-batch type 1 (Table 4). Fig.18 shows that the complexity
of solution does not provide a protective or inactivating effect, as the same con-
centrations were measured in PBS and filtered nitrified urine. The composition
of solution as factor of inactivation could be ruled out and the result displayed
in Fig.16 (effect of active nitrification) confirmed.
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Room temperature (Fig.19) In order to estimate the proportion of inacti-
vation due to the temperature, batches with PBS and nitrified urine without
aeration (type 4 and 5, Table 4) were installed in the same room as the other
batches.
There was no inactivation of the tested bacteria in PBS at room temperature. In
nitrified urine, however, the concentration of ENT lowered of 2-log and 4-log for
S.typhimurium, this inactivation is likely to be due to the presence of nitrifying
bacteria in suspension in nitrified urine.
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Figure 19: Effect of room temperature on inactvation of (ENT, S.typhimurium) in non-
aerated systems
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4.3.3 Summary of inactivation mechanisms
Tests performed on bacteriophages and bacteria are summarised in the table
below (Table 12). As the effect of air-water interface and room temperature in
nitrified urine is unclear due to the presence of the nitrifying bacteria in solution,
the results are not part of the recapitulative table (Table 12).
Table 12: Recapitulation of the effect of inactivation mechanisms on each organism studied
ΦX147 MS2 Qbeta S.typhimurium ENT
Active biological treatment system X X X √ √
Air-water interface in PBS ? X/? √/? X X
Protective matrix effect possible possible possible X X
Room temperature in PBS X X X X X
Remarks can be drawn based on these comparisons:
• The presence of active nitrification affects bacteria relative to controls but
does not affect bacteriophages.
• Bacteriophages might be protected by the nitrified urine (filtered or not)
complex solution. Further tests according to the method described by
Sigstam et al. [31] can test this supposition. This protective effect was
not observed on the tested bacteria.
• Bacteriophage Qbeta appeared to be sensitive to the effect of air-water
interface in PBS. MS2 was apparently not affected by the AWI. But based
on contradictory results with ΦX147, duplicates of the effect of AWI in
PBS with all three bacteriophages should be done.
• Neither bacteriophages nor bacteria were sensitive to exposure at room
temperature in PBS.
In general, bacteriophages ΦX147 and MS2 appeared to be the most resistant.
It is interesting to point out that despite the fact that MS2 and Qbeta have a
similar structure, their reactions were not always similar.
Bacteria were less resistant and were apparently affected mainly by biological
activity.
The results of the tests run in batch and semi-batch MBBRs cannot be extrap-
olated directly to the continuous flow MBBRs. Several parameters were not the
same (reactor dimensions, aeration rate, etc.). Nevertheless, this kind of test per-
mits to evaluate the inactivation mechanisms of the bacteria and bacteriophage
and to inform further experiments on continuous flow MBBRs.
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5 Conclusion
The present study focused on four main points: operating nitrification reactors,
characterising virus and bacteria inactivation with the use of surrogate virus and
estimate different types of inactivation mechanisms.
Two continuous flow nitrification reactors were successfully set-up. Yet, the
nitrification efficiency decreased over time. Given the relatively short period
of this study, it is difficult to determine if the nitrification will stabilise at an
operating rate or if the decrease will continue. Also the frequent and important
sampling might have influenced the reactors stability. With a longer study, a
more stable system can provide information about the effect of the dimension of
the reactor in order to optimise large scale applications.
Inactivation of bacteriophage MS2 in a continuous flow MBBR was monitored
over 60 days. To date, MS2 underwent no inactivation. Based on semi-batch
experiments, MS2 revealed resistant to nitrifying bacteria and to most of the
inactivation mechanisms tested. Therefore it would be interesting to continue
the study over a longer period and to run tests with additional indicator
organisms.
Mechanisms of inactivation of bacteria and bacteriophage were estimated through
several tests. Small batch and semi-batch tests were set-up to provide informa-
tion faster than with a larger reactor. The results of these experiments can be
used as a guideline to run tests in larger continuous flow MBBRs.
In these tests only bacteria were inactivated during active biological nitrifica-
tion. The other mechanisms tested were not efficient at inactivating bacteria. It
appeared that bacteriophages were in general more resistant than bacteria, as ex-
pected. In addition, a protecting effect of the solution composition is suspected.
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A step of the nutrient recovery process is the storage of urine. Several studies
showed that storage is an efficient way to inactivate many pathogens. However,
pathogens can be detected in stored urine used for nitrification, either due to
the resistance of some pathogens to inactivation during storage or because of
insufficient storage time. During storage, bacteria are known to inactivate more
rapidly than viruses. Thus viruses are more likely to be found in nitrification
reactors. Based on the results of this study, they are likely to be also resistant
to the conditions in nitrification reactors. In addition, viruses may receive
protection from components of the nitrified urine.
Therefore, as the VUNA project moves forward, urine treatment for the inacti-
vation of viruses remains an important challenge to address.
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